Download Docs
Export
Print

OPROVDA

99804604 | Trademark citeCite Docket

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed May 5, 2026
Serial No. 99804604
Examining Attorney DAVID WILLIAM BRUNDAGE
Class Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorder; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Smoking cessation preparations; Vaccines for human use; Pharmaceutical preparations for the treatment of sickle cell disease; Pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions; 005; 006; 018; 044; 046; 051; 052
OPROVDA
Case Type Trademark
Status Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six months of the NOA issuance date.
Last Updated: 2 days, 13 hours ago
Filing Date # Docket Text
to view the full docket.